Medtronic (MDT) is a publicly traded Healthcare sector company. As of May 20, 2026, MDT trades at $78.00 with a market cap of $99.27B and a P/E ratio of 21.02. MDT moved -0.65% today. Year to date, MDT is -19.73%; over the trailing twelve months it is -9.52%. Its 52-week range spans $74.40 to $106.33. Analyst consensus is buy with an average price target of $105.58. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MDT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MDT recently traded at $78.00. Market cap is $99.27B. P/E ratio is 21.02. Revenue is $34.76B.
| Metric | Value |
|---|---|
| Price | $78.00 |
| Market Cap | $99.27B |
| P/E Ratio | 21.02 |
| EPS | $3.72 |
| Dividend Yield | 0.71% |
| 52-Week High | $106.33 |
| 52-Week Low | $74.40 |
| Volume | 7.66M |
| Avg Volume | 0 |
| Revenue (TTM) | $34.76B |
| Net Income | $4.79B |
| Gross Margin | 65.51% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $33.54B | $4.69B | $3.63 |
| 2024 | $32.36B | $3.71B | $2.77 |
| 2023 | $31.23B | $3.78B | $2.83 |
| 2022 | $31.69B | $5.06B | $3.75 |
20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $105.58.